TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomised Controlled Trial of an Intervention Delivered by App Instant Messaging to Increase the Acceptability of Effective Contraception Among Young People in Tajikistan
Brief Summary: This randomised controlled trial will establish the effect a contraceptive intervention delivered by mobile phone app instant messaging on the acceptability of effective contraception in Tajikistan. Woman and men aged 16-24 will be randomised to have access to the Tajik Family Planning Alliance's sexual and reproductive health app (control) or the app plus 0-3 instant messages a day for 4 months (intervention). Participants will complete a questionnaire at baseline and 4 months.


Options:
A: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Contraceptive app instant messages, Other: Mobile phone app | Arm Label: Control; Type: PLACEBO_COMPARATOR; Interventions: Other: Mobile phone app | Intervention Type: BEHAVIORAL; Name: Contraceptive app instant messages; Assigned to Arm(s): Intervention | Intervention Type: OTHER; Name: Mobile phone app; Assigned to Arm(s): Control, Intervention
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Other: Cell Phone Intervention | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Cell Phone Intervention; Assigned to Arm(s): 1
C: Arm Label: Kilkari; Type: EXPERIMENTAL; Interventions: Other: Kilkari | Arm Label: Comparison; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Kilkari; Assigned to Arm(s): Kilkari
D: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Other: EpxBreastfeeding, Other: Baby book survey | Arm Label: Control; Type: OTHER; Interventions: Other: Baby book survey | Intervention Type: OTHER; Name: EpxBreastfeeding; Assigned to Arm(s): Intervention | Intervention Type: OTHER; Name: Baby book survey; Assigned to Arm(s): Control, Intervention

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomised Controlled Trial of an Intervention Delivered by App Instant Messaging to Increase the Acceptability of Effective Contraception Among Young People in Tajikistan
Brief Summary: This randomised controlled trial will establish the effect a contraceptive intervention delivered by mobile phone app instant messaging on the acceptability of effective contraception in Tajikistan. Woman and men aged 16-24 will be randomised to have access to the Tajik Family Planning Alliance's sexual and reproductive health app (control) or the app plus 0-3 instant messages a day for 4 months (intervention). Participants will complete a questionnaire at baseline and 4 months.


Options:
A: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Contraceptive app instant messages, Other: Mobile phone app | Arm Label: Control; Type: PLACEBO_COMPARATOR; Interventions: Other: Mobile phone app | Intervention Type: BEHAVIORAL; Name: Contraceptive app instant messages; Assigned to Arm(s): Intervention | Intervention Type: OTHER; Name: Mobile phone app; Assigned to Arm(s): Control, Intervention
B: Arm Label: Standard Treatment; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Self-help materials, Drug: nicotine patch, Behavioral: Counseling | Arm Label: Automated Treatment; Type: EXPERIMENTAL; Interventions: Behavioral: Self-help materials, Drug: nicotine patch, Other: Smartphone-delivered automated treatment | Intervention Type: BEHAVIORAL; Name: Self-help materials; Assigned to Arm(s): Automated Treatment, Standard Treatment | Intervention Type: DRUG; Name: nicotine patch; Assigned to Arm(s): Automated Treatment, Standard Treatment | Intervention Type: BEHAVIORAL; Name: Counseling; Assigned to Arm(s): Standard Treatment | Intervention Type: OTHER; Name: Smartphone-delivered automated treatment; Assigned to Arm(s): Automated Treatment
C: Arm Label: Standard of Care (SoC); Type: NO_INTERVENTION; Interventions: N/A | Arm Label: SoC + iTab; Type: ACTIVE_COMPARATOR; Interventions: Device: SoC + iTab | Intervention Type: DEVICE; Name: SoC + iTab; Assigned to Arm(s): SoC + iTab
D: Intervention Type: BEHAVIORAL; Name: Pulse; Assigned to Arm(s): N/A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomised Controlled Trial of an Intervention Delivered by App Instant Messaging to Increase Use of Effective Contraception Among Young Women in Bolivia
Brief Summary: This randomised controlled trial will establish the effect a contraceptive intervention delivered by mobile phone app instant messaging on use of effective contraception in Bolivia. Woman aged 16-24 will be randomised to have access to Centro de Investigacion, Educacion y Servicios's sexual and reproductive health app (control) or the app plus 0-3 instant messages a day for 4 months (intervention). Participants will complete a questionnaire at baseline and 4 month follow-up.


Options:
A: Arm Label: Control; Type: SHAM_COMPARATOR; Interventions: Behavioral: Wise app with fitness reminders | Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Wise app with medication adherence reminders | Intervention Type: BEHAVIORAL; Name: Wise app with medication adherence reminders; Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: Wise app with fitness reminders; Assigned to Arm(s): Control
B: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Contraceptive instant messages, Other: Mobile phone app | Arm Label: Control; Type: PLACEBO_COMPARATOR; Interventions: Other: Mobile phone app | Intervention Type: BEHAVIORAL; Name: Contraceptive instant messages; Assigned to Arm(s): Intervention | Intervention Type: OTHER; Name: Mobile phone app; Assigned to Arm(s): Control, Intervention
C: Arm Label: 1 Standard Care (SC); Type: NO_INTERVENTION; Interventions: N/A | Arm Label: 2 Standard Care + Educational (SCE); Type: OTHER; Interventions: Behavioral: educational instruction in clinic | Arm Label: 3 Standard Care + Educational + Phone Calls (SCEP); Type: OTHER; Interventions: Behavioral: educational instruction and phone follow-up | Intervention Type: BEHAVIORAL; Name: educational instruction and phone follow-up; Assigned to Arm(s): 3 Standard Care + Educational + Phone Calls (SCEP) | Intervention Type: BEHAVIORAL; Name: educational instruction in clinic; Assigned to Arm(s): 2 Standard Care + Educational (SCE)
D: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Video treatments | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Video treatments | Intervention Type: BEHAVIORAL; Name: Video treatments; Assigned to Arm(s): Control, Intervention

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effects on Vaginal Health and Quality of Life in Postmenopausal Women Using Ultra Low Topic Estriol Before Vaginal Surgery for Pelvic Statics Disorders
Brief Summary: The purpose of this study is to determine whether the vaginal estriol before vaginal surgery for pelvic statics disorders is more efficacy of no estriol treatment on vaginal health and quality of life.


Options:
A: Arm Label: Study Group on estriol vaginal gel; Type: ACTIVE_COMPARATOR; Interventions: Drug: estriol, Procedure: vaginal surgery | Arm Label: Control group, no estriol treatment; Type: ACTIVE_COMPARATOR; Interventions: Procedure: vaginal surgery | Intervention Type: DRUG; Name: estriol; Assigned to Arm(s): Study Group on estriol vaginal gel | Intervention Type: PROCEDURE; Name: vaginal surgery; Assigned to Arm(s): Control group, no estriol treatment, Study Group on estriol vaginal gel
B: Arm Label: Conjugated Estrogen Group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Promestriene, Drug: Estriol, Drug: Vaginal Moisturizer - Cream | Arm Label: Promestriene Group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Conjugated Estrogen, Drug: Estriol, Drug: Vaginal Moisturizer - Cream | Arm Label: Estriol Group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Conjugated Estrogen, Drug: Promestriene, Drug: Vaginal Moisturizer - Cream | Arm Label: Vaginal Moisturizer Cream; Type: PLACEBO_COMPARATOR; Interventions: Drug: Conjugated Estrogen, Drug: Promestriene, Drug: Estriol | Intervention Type: DRUG; Name: Conjugated Estrogen; Assigned to Arm(s): Estriol Group, Promestriene Group, Vaginal Moisturizer Cream | Intervention Type: DRUG; Name: Promestriene; Assigned to Arm(s): Conjugated Estrogen Group, Estriol Group, Vaginal Moisturizer Cream | Intervention Type: DRUG; Name: Estriol; Assigned to Arm(s): Conjugated Estrogen Group, Promestriene Group, Vaginal Moisturizer Cream | Intervention Type: DRUG; Name: Vaginal Moisturizer - Cream; Assigned to Arm(s): Conjugated Estrogen Group, Estriol Group, Promestriene Group
C: Arm Label: Treatment group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Premarin vaginal cream | Arm Label: Control group; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo cream | Intervention Type: DRUG; Name: Premarin vaginal cream; Assigned to Arm(s): Treatment group | Intervention Type: DRUG; Name: Placebo cream; Assigned to Arm(s): Control group
D: Arm Label: Trimo-San group; Type: EXPERIMENTAL; Interventions: Drug: Trimo-San gel | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Trimo-San gel; Assigned to Arm(s): Trimo-San group

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Evaluating Clinic- and Community-Based Pain Self-Care Programs for Low-Income Hispanics on Opioids
Brief Summary: The purpose of this study is to conduct a parallel group, randomized trial of a chronic pain self-management program in clinic or community settings to educate and support low-income, Hispanic patients with chronic pain to adopt evidence-based pain self-care behaviors and activities.


Options:
A: Arm Label: Individual Cognitive Functional Therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Individual Cognitive Functional Therapy | Arm Label: Group Exercise Classes; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Group Exercise Classes | Intervention Type: BEHAVIORAL; Name: Individual Cognitive Functional Therapy; Assigned to Arm(s): Individual Cognitive Functional Therapy | Intervention Type: BEHAVIORAL; Name: Group Exercise Classes; Assigned to Arm(s): Group Exercise Classes
B: Arm Label: Game Condition; Type: EXPERIMENTAL; Interventions: Behavioral: Game | Arm Label: Control Condition; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Game; Assigned to Arm(s): Game Condition
C: Arm Label: Motor Control Exercise Plus Patient Education; Type: EXPERIMENTAL; Interventions: Behavioral: Motor Control Exercise, Behavioral: Patient Education | Arm Label: Motor Control Exercise; Type: EXPERIMENTAL; Interventions: Behavioral: Motor Control Exercise | Arm Label: Patient Education; Type: EXPERIMENTAL; Interventions: Behavioral: Patient Education | Intervention Type: BEHAVIORAL; Name: Motor Control Exercise; Assigned to Arm(s): Motor Control Exercise, Motor Control Exercise Plus Patient Education | Intervention Type: BEHAVIORAL; Name: Patient Education; Assigned to Arm(s): Motor Control Exercise Plus Patient Education, Patient Education
D: Arm Label: Community-based pain self-management; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Community-based pain self-management | Arm Label: Clinic-based pain self-management; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Clinic-based pain self-management | Intervention Type: BEHAVIORAL; Name: Community-based pain self-management; Assigned to Arm(s): Community-based pain self-management | Intervention Type: BEHAVIORAL; Name: Clinic-based pain self-management; Assigned to Arm(s): Clinic-based pain self-management

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Combination Nicotine Patch / Lorcaserin for Smoking Cessation
Brief Summary: This study plans to compare the efficacy of the nicotine patch / lorcaserin combination treatment vs. the nicotine patch alone in terms of leading to a reduction in smoking behavior and withdrawal symptoms.


Options:
A: Arm Label: varenicline; Type: EXPERIMENTAL; Interventions: Drug: Varenicline | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: Varenicline; Assigned to Arm(s): varenicline | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): placebo
B: Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Psychological advice, Drug: Bupropion Pill, Drug: Varenicline Pill | Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Other: So-Lo-Mo, Behavioral: Psychological advice, Drug: Bupropion Pill, Drug: Varenicline Pill | Intervention Type: OTHER; Name: So-Lo-Mo; Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: Psychological advice; Assigned to Arm(s): Control, Intervention | Intervention Type: DRUG; Name: Bupropion Pill; Assigned to Arm(s): Control, Intervention | Intervention Type: DRUG; Name: Varenicline Pill; Assigned to Arm(s): Control, Intervention
C: Arm Label: Varenicline; Type: EXPERIMENTAL; Interventions: Drug: Varenicline | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Varenicline; Assigned to Arm(s): Varenicline | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Lorcaserin + Patch; Type: EXPERIMENTAL; Interventions: Drug: lorcaserin, Drug: nicotine patch | Arm Label: Patch; Type: EXPERIMENTAL; Interventions: Drug: lorcaserin, Drug: nicotine patch, Drug: placebo lorcaserin | Intervention Type: DRUG; Name: lorcaserin; Assigned to Arm(s): Lorcaserin + Patch, Patch | Intervention Type: DRUG; Name: nicotine patch; Assigned to Arm(s): Lorcaserin + Patch, Patch | Intervention Type: DRUG; Name: placebo lorcaserin; Assigned to Arm(s): Patch

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Immunogenicity and Safety of the Diphtheria, Tetanus, Pertussis and Inactivated Poliovirus (DPT-IPV) Vaccine Squarekids Co-administered With GSK Biologicals' Human Rotavirus (HRV) Vaccine Rotarix (GSK444563) in Healthy Infants
Brief Summary: The purpose of this study is to evaluate the immunogenicity and safety of the diphtheria, tetanus, pertussis and inactivated poliovirus (DPT-IPV) vaccine Squarekids administered with or without the GSK Biologicals' liquid Rotarix (HRV) vaccine, in healthy Japanese infants aged 6 - 12 weeks. GSK Biologicals' liquid HRV vaccine Rotarix is licensed in Japan since 2011. Although the concomitant administration of GSK Biologicals' DTP-IPV vaccine has been evaluated during the clinical development of the HRV vaccine, the vaccine differed in composition and route of administration from the DPT-IPV vaccine Squarekids manufactured in Japan. Hence, as requested by the Japanese regulatory authorities, this post-licensure study will evaluate the immunogenicity of the DPT-IPV vaccine manufactured in Japan when co-administered with the liquid HRV vaccine


Options:
A: Arm Label: Liq_A Group; Type: EXPERIMENTAL; Interventions: Biological: HRV PCV-free liquid vaccine | Arm Label: Liq_B Group; Type: EXPERIMENTAL; Interventions: Biological: HRV PCV-free liquid vaccine | Arm Label: Liq_C Group; Type: EXPERIMENTAL; Interventions: Biological: HRV PCV-free liquid vaccine | Arm Label: Lyo Group; Type: ACTIVE_COMPARATOR; Interventions: Biological: Rotarix | Intervention Type: BIOLOGICAL; Name: HRV PCV-free liquid vaccine; Assigned to Arm(s): Liq_A Group, Liq_B Group, Liq_C Group | Intervention Type: BIOLOGICAL; Name: Rotarix; Assigned to Arm(s): Lyo Group
B: Intervention Type: BIOLOGICAL; Name: 2-dose oral live attenuated G1P[8] human rotavirus vaccine; Assigned to Arm(s): N/A
C: Arm Label: Co-administration Group; Type: EXPERIMENTAL; Interventions: Biological: Squarekids, Biological: Rotarix | Arm Label: Staggered Group; Type: ACTIVE_COMPARATOR; Interventions: Biological: Squarekids, Biological: Rotarix | Intervention Type: BIOLOGICAL; Name: Squarekids; Assigned to Arm(s): Co-administration Group, Staggered Group | Intervention Type: BIOLOGICAL; Name: Rotarix; Assigned to Arm(s): Co-administration Group, Staggered Group
D: Intervention Type: BIOLOGICAL; Name: HRV vaccine; Assigned to Arm(s): N/A

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effects of Milk Protein Intake in Young Children on Early Growth and Later Obesity Risk: a Multicentre Randomized Clinical Trial
Brief Summary: To assess growth of children (enrolled between 11.5 and 13.5 months) fed with two iso-energetic, young-child formulas with different protein content during the second year of life


Options:
A: Arm Label: Experimental formula; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Young-child formula with low protein content | Arm Label: Control formula; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Young-child formula with protein content similar to that of cow's milk | Intervention Type: DIETARY_SUPPLEMENT; Name: Young-child formula with low protein content; Assigned to Arm(s): Experimental formula | Intervention Type: DIETARY_SUPPLEMENT; Name: Young-child formula with protein content similar to that of cow's milk; Assigned to Arm(s): Control formula
B: Arm Label: IF-VLP (very low protein); Type: EXPERIMENTAL; Interventions: Other: Infant formula | Arm Label: IF-LP (low protein); Type: OTHER; Interventions: Other: Infant formula | Arm Label: IF-CSP (control standard protein); Type: OTHER; Interventions: Other: Infant formula | Arm Label: HM (human milk); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Infant formula; Assigned to Arm(s): IF-CSP (control standard protein), IF-LP (low protein), IF-VLP (very low protein)
C: Arm Label: Experimental Group; Type: EXPERIMENTAL; Interventions: Other: Modified infant formula | Arm Label: Control Group; Type: ACTIVE_COMPARATOR; Interventions: Other: Standard infant formula | Arm Label: Breast-fed Reference Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Modified infant formula; Assigned to Arm(s): Experimental Group | Intervention Type: OTHER; Name: Standard infant formula; Assigned to Arm(s): Control Group
D: Arm Label: Study Formula (SF); Type: EXPERIMENTAL; Interventions: Other: Study Formula (SF), Other: Comparator Formula (CF) | Arm Label: Comparator Formula (CF); Type: ACTIVE_COMPARATOR; Interventions: Other: Study Formula (SF), Other: Comparator Formula (CF) | Arm Label: Human Milk Reference Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Study Formula (SF); Assigned to Arm(s): Comparator Formula (CF), Study Formula (SF) | Intervention Type: OTHER; Name: Comparator Formula (CF); Assigned to Arm(s): Comparator Formula (CF), Study Formula (SF)

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Targeted Hypothermia Versus Targeted Normothermia After Out-of-hospital Cardiac Arrest (TTM2) - A Randomised Clinical Trial
Brief Summary: ILCOR guidelines recommend Target Temperature Management (TTM) to between 32°C and 36°C after out-of-hospital cardiac arrest, based on low quality evidence. In a previous trial, TTM at 33°C did not confer a survival benefit or improved neurological function, compared to TTM at 36°C. A lower target temperature might be beneficial compared with normothermia and early treatment of fever. Therefore the primary purpose of the TTM2-trial will be to study any differences in mortality, neurological function and quality of life between a target temperature of 33°C and standard care avoiding fever.


Options:
A: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Hypothermia; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Mild therapeutic hypothermia | Intervention Type: PROCEDURE; Name: Mild therapeutic hypothermia; Assigned to Arm(s): Hypothermia
B: Arm Label: Normothermia; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Standard care with early treatment of fever | Arm Label: Hypothermia; Type: EXPERIMENTAL; Interventions: Procedure: Targeted temperature management to 33°C | Intervention Type: PROCEDURE; Name: Targeted temperature management to 33°C; Assigned to Arm(s): Hypothermia | Intervention Type: PROCEDURE; Name: Standard care with early treatment of fever; Assigned to Arm(s): Normothermia
C: Arm Label: Moderate hypothermia; Type: OTHER; Interventions: Other: Therapeutic Hypothermia | Arm Label: Mild Hypothermia; Type: ACTIVE_COMPARATOR; Interventions: Other: Therapeutic Hypothermia | Intervention Type: OTHER; Name: Therapeutic Hypothermia; Assigned to Arm(s): Mild Hypothermia, Moderate hypothermia
D: Arm Label: Targeted controlled temperature between 32.5 and 33.5°C; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Targeted controlled temperature between 32.5 and 33.5°C, Procedure: Targeted controlled temperature between 36.5 and 37.5°C | Arm Label: Targeted controlled temperature between 36.5 and 37.5°C; Type: PLACEBO_COMPARATOR; Interventions: Procedure: Targeted controlled temperature between 36.5 and 37.5°C | Intervention Type: PROCEDURE; Name: Targeted controlled temperature between 32.5 and 33.5°C; Assigned to Arm(s): Targeted controlled temperature between 32.5 and 33.5°C | Intervention Type: PROCEDURE; Name: Targeted controlled temperature between 36.5 and 37.5°C; Assigned to Arm(s): Targeted controlled temperature between 32.5 and 33.5°C, Targeted controlled temperature between 36.5 and 37.5°C

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Cognitive Behavioural Therapy for Anxiety Disorder in Children With Co-morbid Autism Spectrum Disorder
Brief Summary: Children with Autism Spectrum Disorder (ASD) often have other difficulties as a result of the disorder. Up to half of the children with ASD are thought to suffer with anxiety in a way that interferes with their wellbeing and every day functioning. In this project the investigators will study the effect of the group program The Cool Kids Anxiety Program: Autism Spectrum Disorder Adaptation (Cool Kids ASD) - an anxiety treatment program specific developed for children with ASD. The investigators expect a decrease in the overall anxiety level together with an increase in the ability of handling anxiety.


Options:
A: Arm Label: 1. Cognitive Behavioral Therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Behavioral Therapy | Arm Label: 2. Client Centered Therapy; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Client Centered Therapy | Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Therapy; Assigned to Arm(s): 1. Cognitive Behavioral Therapy | Intervention Type: BEHAVIORAL; Name: Client Centered Therapy; Assigned to Arm(s): 2. Client Centered Therapy
B: Arm Label: CBT; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: CBT | Arm Label: WL; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: CBT; Assigned to Arm(s): CBT
C: Arm Label: CBT; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Coping Cat cognitive-behavioral therapy for anxious youth | Arm Label: Waitlist Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Coping Cat cognitive-behavioral therapy for anxious youth; Assigned to Arm(s): CBT
D: Arm Label: Cognitive Behavioral Therapy Condition; Type: EXPERIMENTAL; Interventions: Other: Cognitive Behavioral Therapy | Arm Label: Treatment as Usual; Type: ACTIVE_COMPARATOR; Interventions: Other: Treatment as usual | Intervention Type: OTHER; Name: Cognitive Behavioral Therapy; Assigned to Arm(s): Cognitive Behavioral Therapy Condition | Intervention Type: OTHER; Name: Treatment as usual; Assigned to Arm(s): Treatment as Usual

Answer: B